vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $41.3M, roughly 1.1× Northfield Bancorp, Inc.). GRAIL, Inc. runs the higher net margin — -227.5% vs -1545.5%, a 1318.0% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 15.0%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
GRAL vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $41.3M |
| Net Profit | $-99.2M | $-27.4M |
| Gross Margin | — | — |
| Operating Margin | -285.4% | -1263.3% |
| Net Margin | -227.5% | -1545.5% |
| Revenue YoY | 14.0% | 12.7% |
| Net Profit YoY | -2.2% | -343.6% |
| EPS (diluted) | $-2.37 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $41.3M | ||
| Q3 25 | $36.2M | $39.2M | ||
| Q2 25 | $35.5M | $38.9M | ||
| Q1 25 | $31.8M | $34.8M | ||
| Q4 24 | $38.3M | $36.7M | ||
| Q3 24 | $28.7M | $31.8M | ||
| Q2 24 | $32.0M | $31.5M | ||
| Q1 24 | $26.7M | $31.3M |
| Q4 25 | $-99.2M | $-27.4M | ||
| Q3 25 | $-89.0M | $10.8M | ||
| Q2 25 | $-114.0M | $9.6M | ||
| Q1 25 | $-106.2M | $7.9M | ||
| Q4 24 | $-97.1M | $11.3M | ||
| Q3 24 | $-125.7M | $6.5M | ||
| Q2 24 | $-1.6B | $6.0M | ||
| Q1 24 | $-218.9M | $6.2M |
| Q4 25 | -285.4% | -1263.3% | ||
| Q3 25 | -346.2% | 37.7% | ||
| Q2 25 | -446.9% | 35.6% | ||
| Q1 25 | -482.5% | 31.0% | ||
| Q4 24 | -358.0% | 38.0% | ||
| Q3 24 | -640.5% | 27.9% | ||
| Q2 24 | -5133.8% | 29.1% | ||
| Q1 24 | -851.1% | 27.2% |
| Q4 25 | -227.5% | -1545.5% | ||
| Q3 25 | -245.8% | 27.4% | ||
| Q2 25 | -320.7% | 24.6% | ||
| Q1 25 | -333.6% | 22.6% | ||
| Q4 24 | -253.8% | 30.7% | ||
| Q3 24 | -438.7% | 20.5% | ||
| Q2 24 | -4958.8% | 18.9% | ||
| Q1 24 | -819.3% | 19.9% |
| Q4 25 | $-2.37 | $-0.68 | ||
| Q3 25 | $-2.46 | $0.27 | ||
| Q2 25 | $-3.18 | $0.24 | ||
| Q1 25 | $-3.10 | $0.19 | ||
| Q4 24 | $-1.49 | $0.27 | ||
| Q3 24 | $-3.94 | $0.16 | ||
| Q2 24 | $-51.06 | $0.14 | ||
| Q1 24 | $-7.05 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $690.1M |
| Total Assets | $2.9B | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $164.0M | ||
| Q3 25 | $126.9M | $131.7M | ||
| Q2 25 | $127.4M | $97.6M | ||
| Q1 25 | $133.9M | $101.7M | ||
| Q4 24 | $214.2M | $167.7M | ||
| Q3 24 | $853.6M | $232.9M | ||
| Q2 24 | $958.8M | $153.5M | ||
| Q1 24 | $199.7M | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.6B | $690.1M | ||
| Q3 25 | $2.2B | $719.6M | ||
| Q2 25 | $2.3B | $710.3M | ||
| Q1 25 | $2.4B | $711.1M | ||
| Q4 24 | $2.5B | $704.7M | ||
| Q3 24 | $2.6B | $699.6M | ||
| Q2 24 | $2.7B | $693.0M | ||
| Q1 24 | — | $698.4M |
| Q4 25 | $2.9B | $5.8B | ||
| Q3 25 | $2.6B | $5.7B | ||
| Q2 25 | $2.7B | $5.7B | ||
| Q1 25 | $2.8B | $5.7B | ||
| Q4 24 | $3.0B | $5.7B | ||
| Q3 24 | $3.1B | $5.7B | ||
| Q2 24 | $3.3B | $5.7B | ||
| Q1 24 | — | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $53.7M |
| Free Cash FlowOCF − Capex | $-63.9M | $52.5M |
| FCF MarginFCF / Revenue | -146.5% | 127.1% |
| Capex IntensityCapex / Revenue | 0.2% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $53.7M | ||
| Q3 25 | $-63.2M | $13.9M | ||
| Q2 25 | $-77.0M | $14.1M | ||
| Q1 25 | $-95.0M | $9.4M | ||
| Q4 24 | — | $31.1M | ||
| Q3 24 | $-104.6M | $14.0M | ||
| Q2 24 | $-171.8M | $6.9M | ||
| Q1 24 | $-207.3M | $4.2M |
| Q4 25 | $-63.9M | $52.5M | ||
| Q3 25 | $-63.6M | $13.6M | ||
| Q2 25 | $-77.3M | $13.9M | ||
| Q1 25 | $-95.1M | $9.2M | ||
| Q4 24 | — | $30.0M | ||
| Q3 24 | $-105.6M | $13.7M | ||
| Q2 24 | $-173.2M | $6.7M | ||
| Q1 24 | $-209.8M | $3.8M |
| Q4 25 | -146.5% | 127.1% | ||
| Q3 25 | -175.8% | 34.6% | ||
| Q2 25 | -217.6% | 35.7% | ||
| Q1 25 | -298.6% | 26.3% | ||
| Q4 24 | — | 81.6% | ||
| Q3 24 | -368.4% | 43.2% | ||
| Q2 24 | -541.7% | 21.1% | ||
| Q1 24 | -785.3% | 12.1% |
| Q4 25 | 0.2% | 2.8% | ||
| Q3 25 | 1.1% | 0.8% | ||
| Q2 25 | 1.0% | 0.6% | ||
| Q1 25 | 0.2% | 0.7% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | 3.4% | 0.7% | ||
| Q2 24 | 4.3% | 0.8% | ||
| Q1 24 | 9.5% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
NFBK
Segment breakdown not available.
